Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2016-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.5200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-17-000153
Form type
SC 13G/A
Filer
SPHERA FUNDS MANAGEMENT LTD.
CIK
CIK 1496201
Filed
Jan 24, 2017
Reporting period
Aug 11, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub